drugset / Trial / NCT00637416
Dietary Control Alone Versus Dietary Control Plus Use of Proton Pump Inhibitors to Treat Pediatric Hoarseness
Phase 4
Terminated
9 enrolled
University of Kansas Medical Center
TAP Pharmaceutical Products Inc. · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will examine whether lansoprazole (Prevacid) and dietary control versus dietary control alone will improve pediatric hoarseness symptoms.
Timeline
- Start
- 2008-03
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lansoprazole | Other / unclassified | 30 mg | Oral |